NRC
National Research Corp
NASDAQ: NRC · HEALTHCARE · HEALTH INFORMATION SERVICES
$18.71
+3.73% today
Updated 2026-06-04
Market cap
$431.35M
P/E ratio
49.08
P/S ratio
3.11x
EPS (TTM)
$0.39
Dividend yield
2.84%
52W range
$11 – $23
Volume
0.1M
WallStSmart proprietary scores
48
out of 100
Grade: C
Sell
Investment rating
2.7
Growth
F3.0
Quality
D7.5
Profitability
B+6.7
Valuation
B3/9
Piotroski F-Score
Weak
1.3
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$12.00
-35.86%
12-Month target
$12.00
-35.86%
Intrinsic (DCF)
$27.80
Margin of safety
+50.54%
Price chart
Stock snapshot
Strengths
+ ROE 66.94% — strong efficiency
+ Free cash flow $5.35M — positive
+ 50.54% below intrinsic value
Risks
- Piotroski 3/9 — weak financial health
- Altman Z 1.32 — distress zone
- P/E 49.08x — expensive valuation
- Debt/equity 5.78x — high leverage
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $151.57M | $148.58M | $143.06M | $137.39M | $138.64M |
| Net income | $31.80M | $30.97M | $24.78M | $11.60M | $3.22M |
| EPS | — | — | — | — | $0.39 |
| Free cash flow | $26.43M | $22.33M | $19.18M | $15.74M | $5.35M |
| Profit margin | 20.98% | 20.84% | 17.32% | 8.44% | 6.52% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-12 | RAU, JASON RUSSELL | Buy | 60,000 | — |
| 2026-02-17 | HARRISON, SHANE R | Buy | 8,000 | $12.27 |
| 2026-01-22 | LOCKHART, STEPHEN H | Buy | 8,819 | — |
Peer comparison
Smart narrative
National Research Corp trades at $18.71. representing a P/E of 49.08x trailing earnings. Our Smart Value Score of 48/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 1.32, it sits in the distress. TTM revenue stands at $138.64M. with profit margins at 6.52%. Our DCF model estimates intrinsic value at $27.80.
Frequently asked questions
What is National Research Corp's stock price?
National Research Corp (NRC) trades at $18.71, on a P/E of 49.1x and a P/S of 3.1x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is National Research Corp overvalued?
National Research Corp carries a Smart Value Score of 48/100 (Grade C), which we rate Sell. That score blends growth, quality, and valuation into one read. Our DCF puts intrinsic value at $27.80 versus the $18.71 price, a 50.5% margin of safety on a cash flow basis.
What is the price target of National Research Corp (NRC)?
The 12-month analyst consensus target is $12.00, about 35.9% below the current $18.71. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of National Research Corp (NRC)?
Our DCF model estimates intrinsic value at $27.80, a +50.5% margin of safety versus today's $18.71. Intrinsic value is what the projected cash flows are worth today. A positive reading means the price sits below that estimate, leaving a cushion if growth holds.
What is National Research Corp's revenue?
National Research Corp's trailing twelve-month revenue is $138.64M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
National Research Corp's Altman Z-Score is 1.32, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryHEALTH INFORMATION SERVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio3.11x
ROE66.94%
Beta0.40
50D MA$17.99
200D MA$16.34
Shares out0.02B
Float0.01B
Short ratio—
Avg volume0.1M
Performance
1 week+0.00%
1 month+4.33%
3 months+19.55%
YTD+5.22%
1 year—
3 years—
5 years—